Published in J Acquir Immune Defic Syndr on May 01, 2017
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol (2000) 7.95
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol (2003) 4.15
Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS (2009) 4.02
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology (2007) 3.73
HIV infection and the risk of cancers with and without a known infectious cause. AIDS (2009) 3.13
Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol (2015) 2.40
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol (2008) 2.38
Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med (2010) 2.33
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS (2008) 2.14
Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr (2009) 2.09
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.02
Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol (2005) 1.94
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86
Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS (2014) 1.86
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie (2009) 1.58
Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol (2001) 1.51
Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 1.41
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS (1999) 1.38
Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch Intern Med (2006) 1.30
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS (2009) 1.22
Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst (2015) 1.19
The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer (2005) 1.18
Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects. Gut (2009) 1.11
Metabolic disease in HIV infection. Lancet Infect Dis (2013) 1.11
Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis (2011) 1.08
Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS (2014) 1.05
Cancer treatment disparities in HIV-infected individuals in the United States. J Clin Oncol (2014) 1.04
Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis (2007) 0.97
Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009. J Acquir Immune Defic Syndr (2014) 0.96
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk. Curr Opin HIV AIDS (2014) 0.93
Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev (2015) 0.92
Impact of HIV infection on colorectal tumors: a prospective colonoscopic study of Asian patients. J Acquir Immune Defic Syndr (2014) 0.92
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. Eur J Med Res (2011) 0.91
Inflammatory networks underlying colorectal cancer. Nat Immunol (2016) 0.88
Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis. Metabolism (2015) 0.86
Cancer Incidence in HIV-Infected Versus Uninfected Veterans: Comparison of Cancer Registry and ICD-9 Code Diagnoses. J AIDS Clin Res (2014) 0.84
Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome. BMC Infect Dis (2014) 0.84
Colorectal cancer screening in human immunodeficiency virus population: Are they at average risk? World J Gastrointest Oncol (2012) 0.82
HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts. Infect Agent Cancer (2015) 0.81
Prevalence of gastrointestinal symptoms among ambulatory HIV patients and a control population. Ann Gastroenterol (2012) 0.81
Non-AIDS-Defining Cancer Mortality: Emerging Patterns in the Late HAART Era. J Acquir Immune Defic Syndr (2016) 0.81
Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection. AIDS Care (2013) 0.80
Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer (2015) 0.80
Comparison of colorectal cancer screening and diagnoses in HIV-positive and HIV-negative veterans. AIDS Care (2014) 0.79
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort. HIV Med (2013) 0.79
Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2017) 0.77
Emerging viral STIs among HIV-positive men who have sex with men: the era of hepatitis C virus and human papillomavirus. Sex Transm Infect (2016) 0.76
HIV infection accelerates gastrointestinal tumor outgrowth in NSG-HuPBL mice. AIDS Res Hum Retroviruses (2014) 0.76
Short Communication: Viral Suppression Is Associated with Increased Likelihood of Colorectal Cancer Screening Among Persons Living with HIV/AIDS. AIDS Res Hum Retroviruses (2015) 0.76
Colorectal cancer among persons with HIV: protocol for a systematic review and meta-analysis. Syst Rev (2015) 0.75
A population-based study of the extent of colorectal cancer screening in men with HIV. BMC Health Serv Res (2015) 0.75
Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention. BMC Cancer (2015) 0.75
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine (2008) 4.31
Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine (2008) 2.13
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ (2007) 1.83
Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One (2013) 1.79
Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev (2010) 1.59
Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics (2009) 1.48
Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients. AIDS (2007) 1.47
Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada. AIDS (2002) 1.34
Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction (2003) 1.30
Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr (2015) 1.17
Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS). Int J Epidemiol (2012) 1.14
Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases. Antivir Ther (2010) 1.06
The association of hospital, clinic and provider volume with HIV/AIDS care and mortality: systematic review and meta-analysis. AIDS Care (2011) 1.06
Elevated creatine kinase and myalgia in a patient taking rosiglitazone. Ann Pharmacother (2007) 1.06
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr (2010) 1.05
Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study. BMC Med Res Methodol (2013) 1.01
Provider training and experience for people living with HIV/AIDS. Cochrane Database Syst Rev (2011) 0.96
Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men. Am J Epidemiol (2003) 0.96
Psychosocial impact of repeat HIV-negative testing: a follow-up study. AIDS Behav (2005) 0.95
Effectiveness of aerobic exercise in adults living with HIV/AIDS: systematic review. Med Sci Sports Exerc (2004) 0.92
Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther (2014) 0.92
The impact of stressful life events on unprotected anal intercourse among gay and bisexual men. AIDS Behav (2012) 0.90
Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011. J Acquir Immune Defic Syndr (2015) 0.84
Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors. Antivir Ther (2008) 0.84
Synthetic cannabinoids. CMAJ (2013) 0.84
Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. AIDS (2014) 0.83
Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series. AIDS (2003) 0.82
Factors that affect HIV testing and counseling services among heterosexuals in Canada and the United Kingdom: an integrated review. Patient Educ Couns (2011) 0.82
Pharmacokinetics of maraviroc, raltegravir, darunavir, and etravirine in the semen of HIV-infected men. J Acquir Immune Defic Syndr (2013) 0.82
Vaccination against human papillomavirus. CMAJ (2007) 0.80
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada. J Int Assoc Provid AIDS Care (2013) 0.79
Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohort. AIDS (2013) 0.79
Recent immigrants show improved clinical outcomes at a tertiary care HIV clinic. Can J Infect Dis Med Microbiol (2012) 0.77
Outcomes of dosage adjustments used to manage antiretroviral drug interactions. Clin Infect Dis (2007) 0.77
Impact of acid-suppressive therapy on virologic response to atazanavir-based regimens in antiretroviral-experienced patients: a case series. J Acquir Immune Defic Syndr (2005) 0.76
Advances in human immunodeficiency virus therapeutics. Ann Pharmacother (2006) 0.76
Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophy. HIV Clin Trials (2011) 0.76
Time-dependent bias in hepatitis C classification. Epidemiology (2015) 0.76
A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr (2016) 0.75
Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada. AIDS Care (2013) 0.75
Gastrointestinal Symptom Distress is Associated With Worse Mental and Physical Health-Related Quality of Life. J Acquir Immune Defic Syndr (2017) 0.75
A comparison of dyslipidemias associated with either lopinavir/ritonavir- or indinavir/ritonavir-based antiretroviral therapy. J Acquir Immune Defic Syndr (2004) 0.75
Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities. AIDS (2016) 0.75
Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen. HIV Clin Trials (2007) 0.75
Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada. Can J Public Health (2017) 0.75
Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma. Ann Hematol (2007) 0.75
The use of multistate models to examine associations of stress and adherence with transitions among HIV care states observed in a clinical HIV cohort. J Acquir Immune Defic Syndr (2017) 0.75